Educating Smokers About Lung Cancer Screening Using Tobacco Quitlines
NCT ID: NCT04595422
Last Updated: 2025-10-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
800 participants
INTERVENTIONAL
2020-07-02
2026-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Educating QUitline Callers About Lung Cancer Screening
NCT05046951
The Lung Screening, Tobacco and Health Project
NCT03200236
Smoking Cessation Intervention During Low Dose CT (LDCT) Screening for Lung Cancer
NCT03059940
Testing Informed Decision Making in Lung Cancer Screening
NCT04940221
Designing an Implementation Strategy for Lung Screening and Smoking Cessation Treatment in Community Health Centers
NCT05447897
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
I. To increase the number of smokers eligible for lung cancer screening (LCS) who receive high-quality educational materials about LCS through tobacco quitlines.
OUTLINE:
CALL CENTER STAFF: Participants undergo training consisting of a 60-minute educational session.
CALLERS SUBSTUDY: Participants are referred to lung cancer screening educational materials. Participants also complete questionnaires at 1 week and 6 months after referral to educational materials.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SEQUENTIAL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Call center staff (educational intervention)
Participants undergo training consisting of a 60-minute educational session.
Educational Intervention
Undergo training consisting of a 60-minute educational session
Survey Administration
Ancillary studies
Callers substudy (LCS educational materials, questionnaire)
Participants are referred to lung cancer screening educational materials. Participants also complete questionnaires at 1 week and 6 months after referral to educational materials.
Educational Intervention
Receive lung cancer screening educational materials
Questionnaire Administration
Complete questionnaire
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Educational Intervention
Undergo training consisting of a 60-minute educational session
Educational Intervention
Receive lung cancer screening educational materials
Questionnaire Administration
Complete questionnaire
Survey Administration
Ancillary studies
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Staff member of a quitline
* Aged 18 years and above
* Callers 55-80 years of age
* Current smoker, or former smoker with a cessation history of \< 15 years
* \>= 30 pack-year smoking history
* English-speaking
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
M.D. Anderson Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Robert J Volk
Role: PRINCIPAL_INVESTIGATOR
M.D. Anderson Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
M D Anderson Cancer Center
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Robert J. Volk
Role: primary
Related Links
Access external resources that provide additional context or updates about the study.
M D Anderson Cancer Center
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2020-03812
Identifier Type: REGISTRY
Identifier Source: secondary_id
2020-0013
Identifier Type: OTHER
Identifier Source: secondary_id
2020-0013
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.